Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Xpert Xpress Strep A Test Gets CLIA Waiver

NEW YORK (GenomeWeb) – Cepheid announced today its near-patient assay to detect Group A Strep infection, a common cause of "strep throat" acute pharyngitis, has been CLIA waived.

The test called the Xpert Xpress Strep A test was cleared last year by the US Food and Drug Administration to run on the firm's GeneXpert molecular diagnostics platforms. Cepheid has since obtained FDA clearance and CLIA waiver for two multi-module platforms, called GeneXpert Xpress II and GeneXpert Xpress IV, and a company representative confirmed the Strep A test can run on these other GeneXpert systems as well.

The Xpert Xpress Strep A test detects Streptococcus pyogenes DNA in as little as 18 minutes. The rapid results may facilitate antimicrobial stewardship in the outpatient setting, David Persing, Cepheid's chief medical and technology officer, said in a statement.

The FDA approval also stipulated that there are no requirements for culture confirmation of negative results unless clinical symptoms persist or in situations where there is an outbreak of acute rheumatic fever.

The Xpert Xpress line — faster versions of the firm's Xpert test cartridges that enable test times of 30 minutes or less — was first described by Cepheid in 2015 and also includes Xpert Xpress Flu and Xpert Xpress Flu/RSV.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.